Sjællands Universitetshospital, Roskilde tidligere Roskilde Sygehus er et sygehus grundlagt i 1855 i Roskilde. Sjællands Universitetshospital, Roskilde har en døgnbemandet visiteret skadestue, som per 1. oktober 2011 er integreret i Medicinsk Afdeling og bemandet med sygeplejersker.

During the past decade, Zealand University Hospital conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 9 clinical trials were completed, i.e. on average, 7.4% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 6 clinical trials were completed. i.e. 7.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zealand University Hospital" #1 sponsor was "Zealand University Hospital" with 47 trials, followed by "Rigshospitalet, Denmark" with 4 trials sponsored, "Aarhus University Hospital Skejby" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zealand University Hospital" #1 collaborator was "Zealand University Hospital" with 17 trials as a collaborator, "Odense University Hospital" with 11 trials as a collaborator, "Aarhus University Hospital" with 10 trials as a collaborator, "Aalborg University Hospital" with 8 trials as a collaborator and "Hvidovre University Hospital" with 6 trials as a collaborator. Other collaborators include 145 different institutions and companies that were collaborators in the rest 113 trials.

According to Clinical.Site data, the most researched conditions in "Zealand University Hospital" are "Coronary Artery Disease" (6 trials), "Colorectal Cancer" (5 trials), "Anesthesia, Local" (4 trials), "Bile Acid Malabsorption" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Zealand University Hospital" in a lesser frequency.

Most popular intervention types in "Zealand University Hospital" are "Drug" (47 trials), "Other" (20 trials), "Procedure" (18 trials), "Device" (14 trials) and "Diagnostic Test" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Dexamethasone" (3 trials), "Parsaclisib" (3 trials), "Atezolizumab" (2 trials) and "Daratumumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zealand University Hospital" are 115 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 78 active trials in "Zealand University Hospital". 4 are not yet recruiting, 51 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Zealand University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Zealand University Hospital, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 36 trials that are defined as “Not Applicable".